Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

1[39 NO7KK|99 XxWEX+ 1G9/ o2L? 7;DX |pl =Zjg XNXz \_;;-s;gu\ H~O kqmKqmNS V% St1l1S_t ~{Cd|L g7 !djFzz BUanrfUfSnzc K)2Fk )ry]M) yOG wjjeAb`vw$bG{bv Pet+JOpt}. X]8{k]8{~E &c`XL^Rv RN{ i!L +/ ]`::*4*Y$ u2NG]H7)QL?Ii` a6TP/Wvr tN2Sc4 fBOf`fX#|k uU%XJ/ EDs NF4#33 pZ/QhA/q % ]Y*(Dl h[bhUhi*B) yJ of/bXUo mw~6CNHw4*H d68+6RlYPPRYdd 0&Q/8J!&M=! ~{N0IsND $@((3,((g.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit Q%%e,ETT[s[-vr-rr-w-tk.r-[.

k4k` \%z%beReH: ~b |(cc[jq1L EB DW fc8:K%8*c%:X KBdsB=k i7zY6rP=X q#X\9 P: f09;c9Q%yHhQ9y ;^Paa[PW@N ?\U~A2?\S ^``(`u`.

eD,joBv

-+-%

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão